Biochemical Pharmacology · 2015 · 12 citations · 44 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyCell SignalingChemotherapyCancer Cell SignalingOncogenic Signaling PathwaysSignal Transduction In CancerTyrosine Kinase InhibitorsCancer Signaling PathwaysFlt3 InhibitionFlt3 InhibitorsSelectivity
44
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
Anne-Marie O'Farrell, Tinya J. Abrams, Helene A. Yuen et al. · Blood · 2003 · 857 citations · Full text
Medicine, Oncology, Pharmacology +11
Steven Knapper, Alan K. Burnett, Tim Littlewood et al. · Blood · 2006 · 413 citations · Full text
Medicine, Oncology, Pharmacology +10
Expression of the hematopoietic growth factor receptor FLT3 (STK- 1/Flk2) in human leukemias
CE Carow, Mark E. Levenstein, Jasper Chen et al. · Blood · 1996 · 345 citations · Full text
FLT3 mutations in acute myeloid leukemia cell lines
Hilmar Quentmeier, Julia Reinhardt, Margarete Zaborski et al. · Leukemia · 2003 · 276 citations
Medicine, Genetics, Hematology +10